South Africans need to better understand the potential risks associated with using medication to combat pain, as even the use of certain pain medications, could lead to an individual needing professional help for addiction to opioids...
Cipla 5 Jul 2018
The 2017 cold and flu season is almost upon us again... Insight Survey's latest SA Cold and Flu Industry Landscape Report 2017 carefully unfolds the local cold and flu remedy markets...
Insight Survey 13 Mar 2017
Manufacturers of brand name drugs will not be able to take advantage of the Department of Health's recently announced 7.5% drug price increase for this year, due to cutthroat generic competition that is driving South African drug costs down...
17 Feb 2015
The introduction of several new generic intravenous (IV) therapies in South Africa could keep spiralling healthcare costs in check...
17 Nov 2014
Ask your pharmacist for advice on self-medication to help you make smart health choices.
22 Jul 2014
At an adjudication by the Marketing Code Authority (MCA), which regulates the local pharmaceutical industry, both Roche and Novartis distanced themselves from the recent statement on intellectual property rights by the Swiss Chamber of Commerce, SwissCham Southern Africa.
18 Mar 2014
This week it was confirmed that Kaizer Chiefs player, Josta Dladla, tested positive for the banned stimulant, methylhexanamine, commonly known as 1.3-dimethyl or DMAA, the use of which is banned in professional sport.
17 Jan 2014
It is important for South African consumers to make sure that the pharmaceutical products they purchase are manufactured safely and comply with the necessary standards, as taking unsafe, illegal medicines can have dangerous consequences.
Manfred Boensch 11 Oct 2013
One of South Africa's most popular contraceptives, Yasmin, is the subject of a bitter court battle that pits a generic drugs company against a multinational.
10 Oct 2013
The National Association of Pharmaceutical Manufacturers (NAPM) believes that a switch of 5% of the volume of branded medicines to a generic equivalent could save the healthcare industry and patients in excess of R400-million per year.
26 Sep 2013
The South African public is starting to embrace the use of generic medicines, a trend that the Department of Health is hoping will continue. The generic medicines industry in South Africa provides cost-effective treatment for a wide range of health conditions, hence the theme for National Pharmacy Week, running from 1 - 8 September 2013, is 'Understanding generic medicines'.
3 Sep 2013
Sandoz, the generic pharmaceuticals division of Novartis, has launched the first-to-market generic medicine for the treatment of gastro-oesophageal reflux disease (GORD).
28 Aug 2013
SA skin-care brand Bio-Oil is a worldwide success story, and the core product of Union Swiss, a multi-million dollar company that sells Bio-Oil in over 50 countries worldwide.
26 Aug 2013
Pfizer together with the South African Depression and Anxiety Group (SADAG) are offering South African media the 'Pfizer Mental Health Journalism Awards for 2013/14.
15 Aug 2013
The local cost of healthcare in South Africa continues to spiral, as its lax patent regime lags behind international developments, hampering access to affordable treatment. Brazil has moved to crack down on anti-competitive behaviour in the pharmaceutical industry, but there is little promise that local patients will soon benefit from similar interventions.
Paul Anley 30 Jul 2013
Bringing its investment over the last 18 months to R1bn, Ascendis Health has acquired Solal Technologies and a majority stake in Marltons for approximately R300m. It has made two appointments in these companies.
15 Jul 2013
Recent research by risk solutions firm Inoxico into the external directorships of JSE-listed companies showed that the directors of South Africa's 20 largest companies held on average 14 external directorships.
12 Jul 2013
Despite health insurance often being considered a grudge purchase, private medical aid policyholders in South Africa gave the health insurance industry a satisfaction score of 73 out of 100.
10 Jul 2013
The National Association of Generic Manufacturers (NAPM) maintains that its members could play a bigger role in reducing the costs of medicines in hospitals. This is in response to the call to the Competition Commission to include the pharmaceutical sector in its investigation into the costs of private healthcare, by two of the larger hospital groups, Netcare and Mediclinic.
Dr Anban Pillay 11 Jun 2013
Advertisements for health products must not fall foul of the Code of Practice for the marketing of health products or the Code of Advertising Practice, says Delene Bertasso, senior associate at law firm Adams & Adams.
27 Feb 2013
The Centre for Drug Evaluation and Research of the Food and Drug Administration (FDA) has accepted Adcock Ingram's Research and Development (R&D) facility, which is located in Aeroton, south of Johannesburg. Adcock Ingram's R&D facility is registered with the Medicines Control Council (MCC) as a current Good Manufacturing Practice facility.
2 Nov 2012
Global health agencies and western donors have made great efforts in recent years to subsidise and improve the supply of medicines for diseases affecting the world's poorest people, particularly malaria, tuberculosis (TB) and other deadly infections.
Roger Bate 11 Jul 2012
More than 50% of South Africans today would rather choose a generic over a brand name prescription drug according to IMS Health South Africa, a marketing research company to the healthcare sector.
3 Apr 2012
Growth of the generic pharmaceutical market - locally and globally - is set to rapidly accelerate in 2012, building on the significant momentum the sector achieved last year.
6 Feb 2012
Aspen registered its Andosept trademark in 2005 and launched a pharyngeal product under that name in 2008, in direct competition with the market-leading product Andolex. The Andosept product was placed on pharmacy shelves in packaging similar to that used for Andolex.
12 Jan 2012
In recent news, the Treatment Action Campaign (TAC) has called on government to revise the Patents Act to reduce the patent protection available to pharmaceutical inventions, which the organisation believes is responsible for the high cost of medicines and a delay in the availability of generic medicines.
Dr Joanne Van Harmelen 23 Nov 2011
South African consumers are paying more for their medicine than they could be, says Paul Anley, CEO of Pharma Dynamics. He was speaking at the annual International Generic Pharmaceutical Alliance (IGPA) conference that took place in Cape Town this month.
17 Nov 2011